公开(公告)号：EP1549946B1

公开(公告)日：2016-07-13

申请号：EP03799314.4

申请日：2003-09-30

申请人： Cora Healthcare, Inc.

发明人： COHEN, Eli ,  NAVICKAS, Irene, A.

IPC分类号： G01N33/48 ,  G01N33/86 ,  G01N33/00 ,  C12Q1/56 ,  A61B5/00 ,  G05B21/00 ,  G06F19/00 ,  G01N11/16 ,  G01N11/14

CPC分类号： G06F19/3418 ,  G01N11/14 ,  G01N11/162 ,  G01N11/167 ,  G01N33/86 ,  G06F19/00 ,  G06Q50/22 ,  G16H10/40 ,  G16H50/20

摘要： A procedure for hemostasis and blood management, particularly for cardiovascular procedures, provides: sampling instructions, i.e., when to draw blood samples and how to pre-treat the blood samples, a decision tree to assist the interpretation of hemostasis analysis results allowing for the identification of various coagulopathies, and treatment suggestions related to the hemostasis analysis results. The analysis, interpretation and identification may be conducted by a suitably programmed computer.

公开(公告)号：EP1649292B1

公开(公告)日：2010-04-21

申请号：EP04780140.2

申请日：2004-08-05

申请人： Cora Healthcare, Inc.

发明人： COHEN, Eli ,  COHEN, Roslyn ,  CARROLL, Roger, C.

IPC分类号： G01N33/86

CPC分类号： C12Q1/56

公开(公告)号：EP2035837A1

公开(公告)日：2009-03-18

申请号：EP07762319.7

申请日：2007-05-24

申请人： Cora Healthcare, Inc.

发明人： COHEN, Eli

IPC分类号： G01N33/86

CPC分类号： G01N33/86 ,  G01N2333/974 ,  G01N2800/52

摘要： A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of hemostasis therapies including anticoagulation therapies such as direct thrombin inhibition therapies.

公开(公告)号：EP3218723A1

公开(公告)日：2017-09-20

申请号：EP15805345.4

申请日：2015-11-13

申请人： Cora Healthcare Inc.

发明人： COHEN, Eli ,  RAVIV, Gabriel ,  NAVICKAS, Irene

IPC分类号： G01N33/68

CPC分类号： G01N33/6893 ,  G01N2800/2871

摘要： Apparatus and methods are provided to determine stroke subtype by hemostasis measurement at point of care or first response. A testing apparatus and methods may provide first test to determine an ischemic or hemorrhagic indication and a second test to provide a therapeutic influence before classifying a stroke substype.

摘要翻译： 提供了通过在护理点或首次应答时通过止血测量来确定中风亚型的设备和方法。 测试装置和方法可以提供第一次测试以确定缺血性或出血性指征，并提供第二次测试以在分类中风亚型之前提供治疗影响。

公开(公告)号：EP2035837B1

公开(公告)日：2012-09-05

申请号：EP07762319.7

申请日：2007-05-24

申请人： Cora Healthcare, Inc.

发明人： COHEN, Eli

IPC分类号： G01N33/86

CPC分类号： G01N33/86 ,  G01N2333/974 ,  G01N2800/52

公开(公告)号：EP1601976B1

公开(公告)日：2015-05-06

申请号：EP04716470.2

申请日：2004-03-02

申请人： Cora Healthcare, Inc.

发明人： COHEN, Eli ,  NAVICKAS, Irene, A.

IPC分类号： G01N11/16 ,  G01N33/86

CPC分类号： G01N11/162 ,  G01N11/167 ,  G01N33/86 ,  G01N2800/52

公开(公告)号：EP1549946A4

公开(公告)日：2011-07-20

申请号：EP03799314

申请日：2003-09-30

申请人： CORA HEALTHCARE INC

发明人： COHEN ELI ,  NAVICKAS IRENE A

IPC分类号： G01N11/14 ,  G01N11/16 ,  G01N33/49 ,  G01N33/86 ,  G01N33/48 ,  A61B5/00 ,  C12Q1/56 ,  G01N33/00 ,  G05B21/00 ,  G06F17/60

CPC分类号： G06F19/3418 ,  G01N11/14 ,  G01N11/162 ,  G01N11/167 ,  G01N33/86 ,  G06Q50/22 ,  G16H10/40 ,  G16H50/20

摘要： A procedure for hemostasis and blood management, particularly for cardiovascular procedures, provides: sampling instructions, i.e., when to draw blood samples and how to pre-treat the blood samples, a decision tree to assist the interpretation of hemostasis analysis results allowing for the identification of various coagulopathies, and treatment suggestions related to the hemostasis analysis results. The analysis, interpretation and identification may be conducted by a suitably programmed computer.

公开(公告)号：EP1287349B1

公开(公告)日：2009-08-19

申请号：EP01941938.1

申请日：2001-06-05

申请人： Cora Healthcare, Inc.

发明人： COHEN, Eli

IPC分类号： G01N33/49 ,  G01N33/86

CPC分类号： G01N11/162 ,  G01N11/167 ,  G01N33/86

摘要： A blood coagulation analyzer, such as the Thrombelastograph3 (TEG3) blood coagulation analyzer is utilized to measure continuously in real time, the clotting process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood coagulation parameters. The measured blood coagulation parameters permit confirmation of the attainment of therapeutic level of GPIIb/IIIa receptor blockade, individualized dosing assessment to evaluate attainment of adequate GPIIb/IIIa receptor blockade; individualized dosing assessment required to reach adequate GPIIb/IIIa receptor blockade; illustration of the rate of diminishment of platelet inhibition or inhibition recovery after treatment with platelet-inhibition drugs; evaluation of the interaction effect of a combination of thrombolytic or any other agents or conditions effecting hemostasis and platelet-inhibiting agents on patient hemostasis.